HomeAXSM • NASDAQ
add
Axsome Therapeutics Inc
Previous close
$89.64
Year range
$55.02 - $98.40
Market cap
4.30B USD
Avg Volume
419.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 87.17M | 86.65% |
Operating expense | 155.00M | 53.30% |
Net income | -79.34M | -18.13% |
Net profit margin | -91.03 | 36.71% |
Earnings per share | -1.67 | -8.44% |
EBITDA | -74.16M | -29.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 315.66M | -27.79% |
Total assets | 548.23M | -10.37% |
Total liabilities | 445.37M | 33.81% |
Total equity | 102.85M | — |
Shares outstanding | 48.00M | — |
Price to book | 41.69 | — |
Return on assets | -34.68% | — |
Return on capital | -60.41% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -79.34M | -18.13% |
Cash from operations | -30.11M | 45.60% |
Cash from investing | -52.00K | 60.90% |
Cash from financing | 14.38M | -94.16% |
Net change in cash | -15.78M | -108.28% |
Free cash flow | -906.62K | 97.05% |
About
Founded
2012
Website
Employees
589
